WHO ICTRP trial
Effects of Glucose Insulin Potassium infusion on inflammatory markers in…
IRCT201111238185N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201111238185N1 |
|---|---|
| Public title | Effects of Glucose Insulin Potassium infusion on inflammatory markers in patients with acute heart failure |
| Scientific title | Effects of Glucose Insulin Potassium (GIK) infusion on serum Nt.Pro BNP and Hs-CRP levels in patients with acute heart failure |
| Primary sponsor | Vice chancellor for research and technology, Kermanshah university of medical sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acute heart failure. Heart failure, unspecified;Heart failure, unspecified |
| Interventions | Intervention 1: Intervention group: 1 cc/kg/h GIK solution with formula 300 g/l glucose, 80 meq/l potassium, 50 u/l insulin during 48h. Intervention 2: Control group:placebo-serum isotonic solution with equal volume and speed.;Treatment… |
| Registration date | Dec 14, 2011 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: